INTRODUCTION
Neuritin, candidate plasticity gene 15 (CPG15), was identified from a cDNA library of plasticity-related genes in the hippocampus [1] . It promotes the growth of neural dendrites and axons, and mediates the formation of synaptic circuits [2] [3] [4] . Neuritin is highly conserved in evolution and plays a vital role in the nervous system. Recently, the role of neuritin in the non-nervous system was discovered. In 2011, Han discovered that neuritin promotes the migration of umbilical vein endothelial cells and has no effect on proliferation [5] ; however, no further evidence was found regarding the effect of neuritin on non-neuronal cells. Thus, it is necessary to elucidate whether neuritin influences cell migration, senescence, and proliferation outside of the nervous system. In this study, neuritin-expressing BMSCs were used to evaluate the overall impact of neuritin on cell migration, senescence, and proliferation in non-neuronal cell types.
MATERIAL AND METHODOLOGY
Cell culture and transfection Soas-2 (osteosarcoma cells), HUVECs (human umbilical vein endothelial cells), HVASMCs (human umbilical artery smooth muscle cells), 293T (human embryonic kidney cells), L-02 (liver cells), LOVO (colon cancer cells), HeLa (cervical cancer cells), ECV-304 (bladder epithelial cancer cells), SK (hepatic duct epithelial cells), and QGY (liver cell cancer cells) cells were obtained from the American Type Culture Collection (Manassas, VA). BMSCs (bone marrow mesenchymal stem cells) were kindly provided by Dr. Xiaoling Mu of Shihezi University [6] . The empty pcDNA3.1-His (-) A vector and recombinant pcDNA3.1-His (-) A-neuritin were constructed as previously described [7] . All cells were cultured in 35-mm dishes with Dulbecco's modified Eagle medium (DMEM) with 10% fetal serum (Hyclone, Logan, UT), 100 U · ml -1 penicillin and 100 mg · ml -1 streptomycin (all from Hyclone) in 5% CO 2 at 37°C. The medium was changed every 24 h. The BMSCs were transfected with the empty vector pcDNA3.1-His (-) A (marked BMSCs-3.1) or the recombinant plasmid pcDNA3.1-His (-) A-neuritin (marked BMSCs-neu) using Lipofectamine 2000 (Invitrogen Life Technologies, Carlsbad, CA). According to the instruction manual, 2.0 μg of the DNA plasmid was added to each dish. After 48 h of transfection, 250 µg · ml -1 G418 was added to select stable transfectants.
Reverse-transcription polymerase chain reaction (RT-PCR)
When BMSCs reached three passages, total RNA was extracted using TRIzol (Invitrogen Life Technologies), and 1 μg of RNA was used for the synthesis of first-strand cDNA using the one-step RNA PCR kit (TaKaRa, Dalian, China) and the following cycling conditions: 30 s at 94°C, 30 s at 64°C, and 90 s at 72°C for 30 cycles. PCR products were detected after separation by 1.5% agarose gel electrophoresis.
The oligonucleotide primers were as follows: Neuritin forward, 5'-CCGGAATTC CAATGGGACTTAAGTTGAACGGCAGATAT-3'; neuritin reverse, 5'-CGC GGATCCGAAGGAAAGCCAGGTCGCTAAAGCT-3'; internal reference (β-actin) forward, 5'-CCCATCTACGAGGGCTAT-3'; internal reference (β-actin) reverse, 5'-AAGAAGGAAGGCTGGAAA-3'.
Western blotting
Western blotting was performed as previously described [8] . Protein quantitation was performed by using the Bradford protein assay. Equal amounts of protein were western-blotted for specific antibodies against His-tag mouse monoclonal antibody (1:1000, Merck, Darmstadt, HE, GER) and goat anti-mouse IgG×HRP (1:5000; Bio-Rad Laboratories, Hercules, CA) according to the manufacturer's instructions. Anti-GAPDH monoclonal antibody (1:3000; Shanghai Kangcheng Biotechnology, Shanghai, China) was used as an internal control. Imaging was enhanced by the addition of Super Signal West Femto Trial Kit reagent (ThermoFisher Scientific, Rockford, IL).
Immunohistochemistry
Cultured BMSCs at passage 3 were incubated with a rabbit primary antibody (1:50, Santa Cruz Biotechnology, Santa Cruz, CA), and goat anti-rabbit horseradishperoxidase-conjugated secondary antibody (1:500, Bio-Rad Laboratories) was then utilized. All cells were dyed with 3'-diaminobenzidine (Molecular Probes, Eugene, OR). Images were captured by microscopy (Nikon TS100, Singapore). All measurements were repeated three times.
Cell migration assay
After neuritin was transfected into BMSCs for 48 h, half of the cells cultured with 10% FBS in DMEM were removed by scraping them from the plate. After the remaining cells had been cultured for 24 h, the number of cells that migrated into the cleared area was documented and measured under a microscope (Nikon TS100). All experiments were performed in triplicate.
β-Galactosidase staining
After transfection of neuritin into BMSCs for 48 h, the cells were fixed and stained with the Senescence β-Galactosidase Staining Kit (Cell Signaling Technology), then incubated at 37°C for 24 h. Senescent cells were indicated by blue staining and were photographed under 200× magnification. All tests were repeated three times.
MTT cell viability assay
After transfection of neuritin into BMSCs for 48 h, the cells were plated in 96-well plates and viability was measured using a 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) kit (Roche Diagnostics). Absorbance was measured at 490 nm on a μQuant microplate reader (Bio-Tek Instruments).
Viability was assessed at 1, 2, 3, 4, 5, and 6 days after transfection. All experiments were run in triplicate.
Statistical analysis
Data are expressed as the mean value ± standard deviation (mean ± SD). Statistical analysis was performed using Students' t-test, and significance was defined as p < 0.05.
RESULTS

Neuritin is not expressed in BMSCs
Neuritin expression was examined by immunohistochemistry (Fig. 1A, a-k) . HUVECs, HVSMCs, 293T, Soas-2, L-02, and LOVO cells expressed neuritin (Fig. 1A, a-f ), whereas HeLa, ECV-304, SK and QGY cells and BMSCs were negative for neuritin staining (Fig. 1A, g-k) . Neuritin mRNA expression was evaluated by RT-PCR. Neuritin was expressed in HUVECs, HVSMCs, 293T, Soas-2, L-02, and LOVO cells, but not in BMSCs and HeLa, ECV-304, SK, and QGY cells (Fig. 1B) .
Stable neuritin expression in BMSCs
Neuritin transcript levels were evaluated by RT-PCR. Neuritin expression was significantly higher in BMSC-neu than in BMSC-3.1 ( Fig. 2A) . Neuritin protein levels were also significantly higher in BMSC-neu (Fig. 2B) .
Neuritin promotes migration of BMSCs
The effect of neuritin on the migration of BMSCs was analyzed by wound scratch assay. The number of migrated BMSC-neu was higher than that of BMSC-3.1 (Fig. 3A, B , p = 0.01).
Neuritin inhibits senescence of BMSCs
The β-galactosidase assay was used to explore the influence of neuritin on cell senescence. In comparison to BMSC-3.1, positivity was significantly lower in BMSC-neu (Fig. 4A, B , p = 0.00).
Neuritin reduces the proliferation and viability of BMSCs
The impact of neuritin on cell proliferation was evaluated by cell counting assay. The proliferative capacity of BMSC-neu was significantly lower than that of BMSC-3.1 at every time point (days 2-6) (p = 0.00, Fig. 5A ). The effect of neuritin on viability was evaluated by MTT assay. Viability was significantly lower in BMSC-neu than in BMSC-3.1 (p = 0.00, Fig. 5B ). Morphology studies showed that the BMSCs had a homogeneous spindle-shaped appearance (Fig. 5C-a) . In comparison to BMSC-3.1, BMSC-neu exhibited more pseudopodia and irregular forms (Fig. 5C-b, c) . 
DISCUSSION
Neuritin is a neural trophic factor associated with neural plasticity [9] that plays an important role in neural development and maturation [10] . However, studies on the effect of neuritin in non-neuronal cells are rare. We established a model of neuritin-expressing BMSCs and explored the effect of neuritin expression on cell migration, senescence, and proliferation. We identified the absence of neuritin in BMSCs among 11 cell lines using immunohistochemistry and RT-PCR, and then created BMSCs-neu, which were BMSCs with stable expression of neuritin. Significantly higher migration was found in BMSCs-neu compared to BMSCs-3.1. Our data demonstrated that neuritin enhances migration of BMSCs. In 2011, it was reported for the first time that neuritin promotes the migration of HUVECs [5] , and in 2014, it was found that overexpression of neuritin enhances the migration of cortical neurons [11] . Thus, neuritin improves the migration capacity of BMSCs and endothelial and neural cells. β-Galactosidase is a specific indicator of senescence, and our data showed that positivity, and hence senescence, was remarkably decreased in BMSCs-neu. This may be because neuritin expressed during early development rescues cortical progenitors from apoptosis [12] . Thus, our observation of decreased senescence in BMSCs is consistent with these previous observations in neurons. Neuritin has no reported effect on the proliferation of HUVECs [5] ; however, it has been reported to promote the proliferation of human astrocytoma cells [13] . Therefore, it remains unclear whether neuritin influences cell proliferation. In the present study, we observed that BMSCs-neu showed a reduction in proliferation compared to BMSCs-3.1 and exhibited decreased viability. An apparent paradox in our data is that neuritin reduced senescence but also reduced proliferation. Interestingly, we found that the cell morphology of BMSCs-neu exhibited neuron-like characteristics, which indicated a tendency of cellular differentiation. It is known that a change in cell number is associated with cell proliferation and is also related to cell differentiation. When cells appear differentiated, the proliferation is reduced [14] . Thus, the paradox is explained. In summary, this study reveals the effects of neuritin on stem cells and provides a theoretical basis for a comprehensive understanding of the function of neuritin in non-neuronal cells.
